Small GTPase ARL4C Associated with Various Cancers Affects Microtubule Nucleation
2024

ARL4C and Its Role in Cancer and Microtubule Nucleation

publication 10 minutes Evidence: moderate

Author Information

Author(s): Ulas Evgeniia, Brodsky Ilya, Burakov Anton, Cimpean Anca-Maria

Primary Institution: A.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University

Hypothesis

The small GTPase ARL4C is involved in the regulation of microtubule nucleation in various cancers.

Conclusion

ARL4C may serve as a regulator of the microtubule nucleation process in both normal and cancer cells.

Supporting Evidence

  • ARL4C levels vary significantly across different tissues and cancer types.
  • Increased ARL4C expression in HeLa cells leads to enhanced microtubule nucleation.
  • ARL4C's role in microtubule organization is cell-type specific.

Takeaway

ARL4C is a protein that helps cells build their internal skeleton, and changes in its levels can affect how cells grow and move, especially in cancer.

Methodology

The study used various human and monkey cell lines, treated them with specific agonists, and assessed changes in ARL4C levels and microtubule nucleation through immunoblotting and immunofluorescent staining.

Limitations

The study's findings may not be universally applicable across all cell types, as the response to ARL4C modulation varied among different cell lines.

Digital Object Identifier (DOI)

10.3390/biomedicines12122872

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication